Table of Content

1 Insomnia Medication Market Overview
1.1 Insomnia Medication Product Scope
1.2 Insomnia Medication Segment by Type
1.2.1 Global Insomnia Medication Sales by Type (2016 & 2021 & 2027)
1.2.2 Nonbenzodiazepine Receptor Agonists
1.2.3 Benzodiazepine Receptor Agonists
1.2.4 The Selective Melatonin Receptor Agonist Ramelteon
1.2.5 Sedating Antidepressants
1.3 Insomnia Medication Segment by Application
1.3.1 Global Insomnia Medication Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Adults
1.3.3 Kids
1.4 Insomnia Medication Market Estimates and Forecasts (2016-2027)
1.4.1 Global Insomnia Medication Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Insomnia Medication Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Insomnia Medication Price Trends (2016-2027)

2 Insomnia Medication Estimates and Forecasts by Region
2.1 Global Insomnia Medication Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Insomnia Medication Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Insomnia Medication Sales Market Share by Region (2016-2021)
2.2.2 Global Insomnia Medication Revenue Market Share by Region (2016-2021)
2.3 Global Insomnia Medication Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Insomnia Medication Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Insomnia Medication Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Insomnia Medication Estimates and Projections (2016-2027)
2.4.2 Europe Insomnia Medication Estimates and Projections (2016-2027)
2.4.3 China Insomnia Medication Estimates and Projections (2016-2027)
2.4.4 Japan Insomnia Medication Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Insomnia Medication Estimates and Projections (2016-2027)
2.4.6 India Insomnia Medication Estimates and Projections (2016-2027)

3 Global Insomnia Medication Competition Landscape by Players
3.1 Global Top Insomnia Medication Players by Sales (2016-2021)
3.2 Global Top Insomnia Medication Players by Revenue (2016-2021)
3.3 Global Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Medication as of 2020)
3.4 Global Insomnia Medication Average Price by Company (2016-2021)
3.5 Manufacturers Insomnia Medication Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Insomnia Medication Market Size by Type
4.1 Global Insomnia Medication Historic Market Review by Type (2016-2021)
4.1.1 Global Insomnia Medication Sales Market Share by Type (2016-2021)
4.1.2 Global Insomnia Medication Revenue Market Share by Type (2016-2021)
4.1.3 Global Insomnia Medication Price by Type (2016-2021)
4.2 Global Insomnia Medication Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Insomnia Medication Sales Forecast by Type (2022-2027)
4.2.2 Global Insomnia Medication Revenue Forecast by Type (2022-2027)
4.2.3 Global Insomnia Medication Price Forecast by Type (2022-2027)

5 Global Insomnia Medication Market Size by Application
5.1 Global Insomnia Medication Historic Market Review by Application (2016-2021)
5.1.1 Global Insomnia Medication Sales Market Share by Application (2016-2021)
5.1.2 Global Insomnia Medication Revenue Market Share by Application (2016-2021)
5.1.3 Global Insomnia Medication Price by Application (2016-2021)
5.2 Global Insomnia Medication Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Insomnia Medication Sales Forecast by Application (2022-2027)
5.2.2 Global Insomnia Medication Revenue Forecast by Application (2022-2027)
5.2.3 Global Insomnia Medication Price Forecast by Application (2022-2027)

6 North America Insomnia Medication Market Facts & Figures
6.1 North America Insomnia Medication Sales by Company
6.1.1 North America Insomnia Medication Sales by Company (2016-2021)
6.1.2 North America Insomnia Medication Revenue by Company (2016-2021)
6.2 North America Insomnia Medication Sales Breakdown by Type
6.2.1 North America Insomnia Medication Sales Breakdown by Type (2016-2021)
6.2.2 North America Insomnia Medication Sales Breakdown by Type (2022-2027)
6.3 North America Insomnia Medication Sales Breakdown by Application
6.3.1 North America Insomnia Medication Sales Breakdown by Application (2016-2021)
6.3.2 North America Insomnia Medication Sales Breakdown by Application (2022-2027)

7 Europe Insomnia Medication Market Facts & Figures
7.1 Europe Insomnia Medication Sales by Company
7.1.1 Europe Insomnia Medication Sales by Company (2016-2021)
7.1.2 Europe Insomnia Medication Revenue by Company (2016-2021)
7.2 Europe Insomnia Medication Sales Breakdown by Type
7.2.1 Europe Insomnia Medication Sales Breakdown by Type (2016-2021)
7.2.2 Europe Insomnia Medication Sales Breakdown by Type (2022-2027)
7.3 Europe Insomnia Medication Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Insomnia Medication Market Facts & Figures
8.1 China Insomnia Medication Sales by Company
8.1.1 China Insomnia Medication Sales by Company (2016-2021)
8.1.2 China Insomnia Medication Revenue by Company (2016-2021)
8.2 China Insomnia Medication Sales Breakdown by Type
8.2.1 China Insomnia Medication Sales Breakdown by Type (2016-2021)
8.2.2 China Insomnia Medication Sales Breakdown by Type (2022-2027)
8.3 China Insomnia Medication Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Insomnia Medication Market Facts & Figures
9.1 Japan Insomnia Medication Sales by Company
9.1.1 Japan Insomnia Medication Sales by Company (2016-2021)
9.1.2 Japan Insomnia Medication Revenue by Company (2016-2021)
9.2 Japan Insomnia Medication Sales Breakdown by Type
9.2.1 Japan Insomnia Medication Sales Breakdown by Type (2016-2021)
9.2.2 Japan Insomnia Medication Sales Breakdown by Type (2022-2027)
9.3 Japan Insomnia Medication Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Insomnia Medication Market Facts & Figures
10.1 Southeast Asia Insomnia Medication Sales by Company
10.1.1 Southeast Asia Insomnia Medication Sales by Company (2016-2021)
10.1.2 Southeast Asia Insomnia Medication Revenue by Company (2016-2021)
10.2 Southeast Asia Insomnia Medication Sales Breakdown by Type
10.2.1 Southeast Asia Insomnia Medication Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Insomnia Medication Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Insomnia Medication Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Insomnia Medication Market Facts & Figures
11.1 India Insomnia Medication Sales by Company
11.1.1 India Insomnia Medication Sales by Company (2016-2021)
11.1.2 India Insomnia Medication Revenue by Company (2016-2021)
11.2 India Insomnia Medication Sales Breakdown by Type
11.2.1 India Insomnia Medication Sales Breakdown by Type (2016-2021)
11.2.2 India Insomnia Medication Sales Breakdown by Type (2022-2027)
11.3 India Insomnia Medication Sales Breakdown by Application
11.3.1 India Insomnia Medication Sales Breakdown by Application (2016-2021)
11.3.2 India Insomnia Medication Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Insomnia Medication Business
12.1 Eisai
12.1.1 Eisai Corporation Information
12.1.2 Eisai Business Overview
12.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Eisai Insomnia Medication Products Offered
12.1.5 Eisai Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Insomnia Medication Products Offered
12.2.5 Merck Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Insomnia Medication Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Insomnia Medication Products Offered
12.4.5 Sanofi Recent Development
12.5 Takeda
12.5.1 Takeda Corporation Information
12.5.2 Takeda Business Overview
12.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Takeda Insomnia Medication Products Offered
12.5.5 Takeda Recent Development
12.6 Vanda Pharmaceuticals
12.6.1 Vanda Pharmaceuticals Corporation Information
12.6.2 Vanda Pharmaceuticals Business Overview
12.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Vanda Pharmaceuticals Insomnia Medication Products Offered
12.6.5 Vanda Pharmaceuticals Recent Development
12.7 Astellas
12.7.1 Astellas Corporation Information
12.7.2 Astellas Business Overview
12.7.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Astellas Insomnia Medication Products Offered
12.7.5 Astellas Recent Development
12.8 Dainippon Sumitomo
12.8.1 Dainippon Sumitomo Corporation Information
12.8.2 Dainippon Sumitomo Business Overview
12.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dainippon Sumitomo Insomnia Medication Products Offered
12.8.5 Dainippon Sumitomo Recent Development
12.9 ECR Pharmaceuticals (Valeant)
12.9.1 ECR Pharmaceuticals (Valeant) Corporation Information
12.9.2 ECR Pharmaceuticals (Valeant) Business Overview
12.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products Offered
12.9.5 ECR Pharmaceuticals (Valeant) Recent Development
12.10 Flynn Pharma
12.10.1 Flynn Pharma Corporation Information
12.10.2 Flynn Pharma Business Overview
12.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Flynn Pharma Insomnia Medication Products Offered
12.10.5 Flynn Pharma Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Business Overview
12.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Insomnia Medication Products Offered
12.11.5 Johnson & Johnson Recent Development
12.12 Meda
12.12.1 Meda Corporation Information
12.12.2 Meda Business Overview
12.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Meda Insomnia Medication Products Offered
12.12.5 Meda Recent Development
12.13 Somnus Therapeutics
12.13.1 Somnus Therapeutics Corporation Information
12.13.2 Somnus Therapeutics Business Overview
12.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Somnus Therapeutics Insomnia Medication Products Offered
12.13.5 Somnus Therapeutics Recent Development
12.14 Purdue Pharma
12.14.1 Purdue Pharma Corporation Information
12.14.2 Purdue Pharma Business Overview
12.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Purdue Pharma Insomnia Medication Products Offered
12.14.5 Purdue Pharma Recent Development
12.15 Neurim
12.15.1 Neurim Corporation Information
12.15.2 Neurim Business Overview
12.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Neurim Insomnia Medication Products Offered
12.15.5 Neurim Recent Development
12.16 Minerva Neurosciences
12.16.1 Minerva Neurosciences Corporation Information
12.16.2 Minerva Neurosciences Business Overview
12.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Minerva Neurosciences Insomnia Medication Products Offered
12.16.5 Minerva Neurosciences Recent Development
12.17 Pernix Therapeutics
12.17.1 Pernix Therapeutics Corporation Information
12.17.2 Pernix Therapeutics Business Overview
12.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Pernix Therapeutics Insomnia Medication Products Offered
12.17.5 Pernix Therapeutics Recent Development
12.18 SkyePharma
12.18.1 SkyePharma Corporation Information
12.18.2 SkyePharma Business Overview
12.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.18.4 SkyePharma Insomnia Medication Products Offered
12.18.5 SkyePharma Recent Development
12.19 Paratek Pharmaceuticals
12.19.1 Paratek Pharmaceuticals Corporation Information
12.19.2 Paratek Pharmaceuticals Business Overview
12.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Paratek Pharmaceuticals Insomnia Medication Products Offered
12.19.5 Paratek Pharmaceuticals Recent Development

13 Insomnia Medication Manufacturing Cost Analysis
13.1 Insomnia Medication Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Insomnia Medication
13.4 Insomnia Medication Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Insomnia Medication Distributors List
14.3 Insomnia Medication Customers

15 Market Dynamics
15.1 Insomnia Medication Market Trends
15.2 Insomnia Medication Drivers
15.3 Insomnia Medication Market Challenges
15.4 Insomnia Medication Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Insomnia Medication Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Insomnia Medication Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Insomnia Medication Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Insomnia Medication Sales (K Pcs) by Region (2016-2021)
Table 5. Global Insomnia Medication Sales Market Share by Region (2016-2021)
Table 6. Global Insomnia Medication Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Insomnia Medication Revenue Share by Region (2016-2021)
Table 8. Global Insomnia Medication Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Insomnia Medication Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Insomnia Medication Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Insomnia Medication Revenue Share Forecast by Region (2022-2027)
Table 12. Global Insomnia Medication Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Insomnia Medication Sales Share by Company (2016-2021)
Table 14. Global Insomnia Medication Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Insomnia Medication Revenue Share by Company (2016-2021)
Table 16. Global Insomnia Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Medication as of 2020)
Table 17. Global Insomnia Medication Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Insomnia Medication Manufacturing Sites and Area Served
Table 19. Manufacturers Insomnia Medication Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Insomnia Medication Sales (K Pcs) by Type (2016-2021)
Table 22. Global Insomnia Medication Sales Share by Type (2016-2021)
Table 23. Global Insomnia Medication Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Insomnia Medication Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Insomnia Medication Sales Share by Type (2022-2027)
Table 26. Global Insomnia Medication Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Insomnia Medication Revenue Share by Type (2022-2027)
Table 28. Global Insomnia Medication Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Insomnia Medication Sales (K Pcs) by Application (2016-2021)
Table 30. Global Insomnia Medication Sales Share by Application (2016-2021)
Table 31. Global Insomnia Medication Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Insomnia Medication Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Insomnia Medication Sales (K Pcs) by Application (2022-2027)
Table 34. Global Insomnia Medication Sales Share by Application (2022-2027)
Table 35. Global Insomnia Medication Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Insomnia Medication Revenue Share by Application (2022-2027)
Table 37. Global Insomnia Medication Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Insomnia Medication Sales (K Pcs) by Company (2016-2021)
Table 39. North America Insomnia Medication Sales Market Share by Company (2016-2021)
Table 40. North America Insomnia Medication Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Insomnia Medication Revenue Market Share by Company (2016-2021)
Table 42. North America Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Insomnia Medication Sales Market Share by Type (2016-2021)
Table 44. North America Insomnia Medication Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Insomnia Medication Sales Market Share by Type (2022-2027)
Table 46. North America Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Insomnia Medication Sales Market Share by Application (2016-2021)
Table 48. North America Insomnia Medication Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Insomnia Medication Sales Market Share by Application (2022-2027)
Table 50. Europe Insomnia Medication Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Insomnia Medication Sales Market Share by Company (2016-2021)
Table 52. Europe Insomnia Medication Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Insomnia Medication Revenue Market Share by Company (2016-2021)
Table 54. Europe Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Insomnia Medication Sales Market Share by Type (2016-2021)
Table 56. Europe Insomnia Medication Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Insomnia Medication Sales Market Share by Type (2022-2027)
Table 58. Europe Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Insomnia Medication Sales Market Share by Application (2016-2021)
Table 60. Europe Insomnia Medication Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Insomnia Medication Sales Market Share by Application (2022-2027)
Table 62. China Insomnia Medication Sales (K Pcs) by Company (2016-2021)
Table 63. China Insomnia Medication Sales Market Share by Company (2016-2021)
Table 64. China Insomnia Medication Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Insomnia Medication Revenue Market Share by Company (2016-2021)
Table 66. China Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 67. China Insomnia Medication Sales Market Share by Type (2016-2021)
Table 68. China Insomnia Medication Sales by Type (2022-2027) & (K Pcs)
Table 69. China Insomnia Medication Sales Market Share by Type (2022-2027)
Table 70. China Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 71. China Insomnia Medication Sales Market Share by Application (2016-2021)
Table 72. China Insomnia Medication Sales by Application (2022-2027) & (K Pcs)
Table 73. China Insomnia Medication Sales Market Share by Application (2022-2027)
Table 74. Japan Insomnia Medication Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Insomnia Medication Sales Market Share by Company (2016-2021)
Table 76. Japan Insomnia Medication Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Insomnia Medication Revenue Market Share by Company (2016-2021)
Table 78. Japan Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Insomnia Medication Sales Market Share by Type (2016-2021)
Table 80. Japan Insomnia Medication Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Insomnia Medication Sales Market Share by Type (2022-2027)
Table 82. Japan Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Insomnia Medication Sales Market Share by Application (2016-2021)
Table 84. Japan Insomnia Medication Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Insomnia Medication Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Insomnia Medication Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Insomnia Medication Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Insomnia Medication Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Insomnia Medication Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Insomnia Medication Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Insomnia Medication Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Insomnia Medication Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Insomnia Medication Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Insomnia Medication Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Insomnia Medication Sales Market Share by Application (2022-2027)
Table 98. India Insomnia Medication Sales (K Pcs) by Company (2016-2021)
Table 99. India Insomnia Medication Sales Market Share by Company (2016-2021)
Table 100. India Insomnia Medication Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Insomnia Medication Revenue Market Share by Company (2016-2021)
Table 102. India Insomnia Medication Sales by Type (2016-2021) & (K Pcs)
Table 103. India Insomnia Medication Sales Market Share by Type (2016-2021)
Table 104. India Insomnia Medication Sales by Type (2022-2027) & (K Pcs)
Table 105. India Insomnia Medication Sales Market Share by Type (2022-2027)
Table 106. India Insomnia Medication Sales by Application (2016-2021) & (K Pcs)
Table 107. India Insomnia Medication Sales Market Share by Application (2016-2021)
Table 108. India Insomnia Medication Sales by Application (2022-2027) & (K Pcs)
Table 109. India Insomnia Medication Sales Market Share by Application (2022-2027)
Table 110. Eisai Corporation Information
Table 111. Eisai Description and Business Overview
Table 112. Eisai Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Eisai Insomnia Medication Product
Table 114. Eisai Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Merck Insomnia Medication Product
Table 119. Merck Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Pfizer Insomnia Medication Product
Table 124. Pfizer Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Sanofi Insomnia Medication Product
Table 129. Sanofi Recent Development
Table 130. Takeda Corporation Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Takeda Insomnia Medication Product
Table 134. Takeda Recent Development
Table 135. Vanda Pharmaceuticals Corporation Information
Table 136. Vanda Pharmaceuticals Description and Business Overview
Table 137. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Vanda Pharmaceuticals Insomnia Medication Product
Table 139. Vanda Pharmaceuticals Recent Development
Table 140. Astellas Corporation Information
Table 141. Astellas Description and Business Overview
Table 142. Astellas Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Astellas Insomnia Medication Product
Table 144. Astellas Recent Development
Table 145. Dainippon Sumitomo Corporation Information
Table 146. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Dainippon Sumitomo Description and Business Overview
Table 148. Dainippon Sumitomo Insomnia Medication Product
Table 149. Dainippon Sumitomo Recent Development
Table 150. ECR Pharmaceuticals (Valeant) Corporation Information
Table 151. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. ECR Pharmaceuticals (Valeant) Description and Business Overview
Table 153. ECR Pharmaceuticals (Valeant) Insomnia Medication Product
Table 154. ECR Pharmaceuticals (Valeant) Recent Development
Table 155. Flynn Pharma Corporation Information
Table 156. Flynn Pharma Description and Business Overview
Table 157. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Flynn Pharma Insomnia Medication Product
Table 159. Flynn Pharma Recent Development
Table 160. Johnson & Johnson Corporation Information
Table 161. Johnson & Johnson Description and Business Overview
Table 162. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Johnson & Johnson Insomnia Medication Product
Table 164. Johnson & Johnson Recent Development
Table 165. Meda Corporation Information
Table 166. Meda Description and Business Overview
Table 167. Meda Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Meda Insomnia Medication Product
Table 169. Meda Recent Development
Table 170. Somnus Therapeutics Corporation Information
Table 171. Somnus Therapeutics Description and Business Overview
Table 172. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Somnus Therapeutics Insomnia Medication Product
Table 174. Somnus Therapeutics Recent Development
Table 175. Purdue Pharma Corporation Information
Table 176. Purdue Pharma Description and Business Overview
Table 177. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Purdue Pharma Insomnia Medication Product
Table 179. Purdue Pharma Recent Development
Table 180. Neurim Corporation Information
Table 181. Neurim Description and Business Overview
Table 182. Neurim Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Neurim Insomnia Medication Product
Table 184. Neurim Recent Development
Table 185. Minerva Neurosciences Corporation Information
Table 186. Minerva Neurosciences Description and Business Overview
Table 187. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Minerva Neurosciences Insomnia Medication Product
Table 189. Minerva Neurosciences Recent Development
Table 190. Pernix Therapeutics Corporation Information
Table 191. Pernix Therapeutics Description and Business Overview
Table 192. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Pernix Therapeutics Insomnia Medication Product
Table 194. Pernix Therapeutics Recent Development
Table 195. SkyePharma Corporation Information
Table 196. SkyePharma Description and Business Overview
Table 197. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. SkyePharma Insomnia Medication Product
Table 199. SkyePharma Recent Development
Table 200. Paratek Pharmaceuticals Corporation Information
Table 201. Paratek Pharmaceuticals Description and Business Overview
Table 202. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 203. Paratek Pharmaceuticals Insomnia Medication Product
Table 204. Paratek Pharmaceuticals Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Insomnia Medication Distributors List
Table 208. Insomnia Medication Customers List
Table 209. Insomnia Medication Market Trends
Table 210. Insomnia Medication Market Drivers
Table 211. Insomnia Medication Market Challenges
Table 212. Insomnia Medication Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Insomnia Medication Product Picture
Figure 2. Global Insomnia Medication Sales Market Share by Type in 2021 & 2027
Figure 3. Nonbenzodiazepine Receptor Agonists Product Picture
Figure 4. Benzodiazepine Receptor Agonists Product Picture
Figure 5. The Selective Melatonin Receptor Agonist Ramelteon Product Picture
Figure 6. Sedating Antidepressants Product Picture
Figure 7. Global Insomnia Medication Sales Market Share by Application in 2021 & 2027
Figure 8. Adults Examples
Figure 9. Kids Examples
Figure 10. Global Insomnia Medication Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Insomnia Medication Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Insomnia Medication Sales (K Pcs) Growth Rate (2016-2027)
Figure 13. Global Insomnia Medication Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 14. Global Insomnia Medication Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Insomnia Medication Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Insomnia Medication Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Insomnia Medication Sales (K Pcs) Growth Rate (2016-2027)
Figure 18. Europe Insomnia Medication Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Insomnia Medication Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Insomnia Medication Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Insomnia Medication Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Insomnia Medication Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Insomnia Medication Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Insomnia Medication Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Insomnia Medication Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Insomnia Medication Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Insomnia Medication Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Insomnia Medication Players Market Share by Revenue in Insomnia Medication: 2016 & 2020
Figure 29. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Insomnia Medication Revenue Share by Type (2016-2021)
Figure 31. Global Insomnia Medication Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Insomnia Medication Revenue Share by Application (2016-2021)
Figure 33. Global Insomnia Medication Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Insomnia Medication Sales Market Share by Type in 2020
Figure 35. North America Insomnia Medication Sales Market Share by Application in 2020
Figure 36. Europe Insomnia Medication Sales Market Share by Type in 2020
Figure 37. Europe Insomnia Medication Sales Market Share by Application in 2020
Figure 38. China Insomnia Medication Sales Market Share by Type in 2020
Figure 39. China Insomnia Medication Sales Market Share by Application in 2020
Figure 40. Japan Insomnia Medication Sales Market Share by Type in 2020
Figure 41. Japan Insomnia Medication Sales Market Share by Application in 2020
Figure 42. Southeast Asia Insomnia Medication Sales Market Share by Type in 2020
Figure 43. Southeast Asia Insomnia Medication Sales Market Share by Application in 2020
Figure 44. India Insomnia Medication Sales Market Share by Type in 2020
Figure 45. India Insomnia Medication Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Insomnia Medication
Figure 48. Manufacturing Process Analysis of Insomnia Medication
Figure 49. Insomnia Medication Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed